Doublet Arms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Doublet Arms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Doublet Arms Today - Breaking & Trending Today

Aptose Reports Results for the First Quarter 2023

Published: May 8, 2023

08.05.2023 - ─ Tuspetinib Dose Escalation and Dose Exploration Trial Completed and Delivered Clinical Responses as Monotherapy Over Four Dose Levels in Very Difficult to Treat AML Patient Populations ─ ─ Doublet of Tuspetinib and Venetoclax Dosing Underway for ...

Source: wallstreet-online.de

Related Topics:

United StatesTuspetinib MonotherapyAptose BiosciencesSusan PietropaoloAmerican Society Of HematologyEuropean School Of HaematologyExchange CommissionDrug AdministrationAptose Biosciences IncCorporate Communications Investor RelationsEuropean Hematology AssociationBrisk EnrollmentDoublet ArmsClinical Activity Already NotedTuspetinib Superior Safety Profile ContinuesChief ExecutiveSafety ReviewDose EscalationExploration ArmsHematology AssociationAmerican SocietyAnnual MeetingOperations DataCall WebcastWebcast Only